Aetna Company Profile (NYSE:AET)

About Aetna (NYSE:AET)

Aetna logoAetna Inc. is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. It offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, medical management capabilities, Medicaid healthcare management services, Medicare Advantage and Medicare Supplement plans, workers' compensation administrative services and health information technology (HIT) products and services. The Health Care segment consists of medical, pharmacy benefit management services, dental, behavioral health and vision plans offered on both an Insured basis and an employer-funded basis, and emerging businesses products and services. The Group Insurance segment includes group life insurance and group disability products. Its products are offered on an Insured basis.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Managed Health Care - NEC
  • Sub-Industry: Managed Health Care
  • Symbol: NYSE:AET
  • CUSIP: 00817Y10
  • Web:
  • Market Cap: $50.14973 billion
  • Outstanding Shares: 331,700,000
Average Prices:
  • 50 Day Moving Avg: $145.02
  • 200 Day Moving Avg: $131.45
  • 52 Week Range: $104.59 - $152.35
  • Trailing P/E Ratio: 46.11
  • Foreward P/E Ratio: 15.21
  • P/E Growth: 1.42
Sales & Book Value:
  • Annual Revenue: $62.63 billion
  • Price / Sales: 0.80
  • Book Value: $42.99 per share
  • Price / Book: 3.52
  • Annual Dividend: $2.00
  • Dividend Yield: 1.3%
  • EBIDTA: $5.73 billion
  • Net Margins: 1.84%
  • Return on Equity: 17.75%
  • Return on Assets: 4.53%
  • Debt-to-Equity Ratio: 0.57%
  • Current Ratio: 0.47%
  • Quick Ratio: 0.47%
  • Average Volume: 2.40 million shs.
  • Beta: 0.48
  • Short Ratio: 3.37

Frequently Asked Questions for Aetna (NYSE:AET)

What is Aetna's stock symbol?

Aetna trades on the New York Stock Exchange (NYSE) under the ticker symbol "AET."

How often does Aetna pay dividends? What is the dividend yield for Aetna?

Aetna announced a quarterly dividend on Friday, May 19th. Shareholders of record on Thursday, July 13th will be paid a dividend of $0.50 per share on Friday, July 28th. This represents a $2.00 dividend on an annualized basis and a yield of 1.32%. The ex-dividend date of this dividend is Tuesday, July 11th. View Aetna's Dividend History.

How will Aetna's stock buyback program work?

Aetna announced that its board has initiated a stock repurchase program on Friday, April 7th 2017, which authorizes the company to repurchase $4,000,000,000.00 in shares, according to EventVestor. This repurchase authorization authorizes the company to repurchase up to 98% of its stock through open market purchases. Stock repurchase programs are often an indication that the company's board believes its stock is undervalued.

How were Aetna's earnings last quarter?

Aetna Inc. (NYSE:AET) released its earnings results on Tuesday, May, 2nd. The company reported $2.71 earnings per share for the quarter, beating the consensus estimate of $2.36 by $0.35. The company earned $15.17 billion during the quarter, compared to analyst estimates of $15.39 billion. Aetna had a net margin of 1.84% and a return on equity of 17.75%. Aetna's quarterly revenue was down 3.4% on a year-over-year basis. During the same period last year, the business posted $2.30 earnings per share. View Aetna's Earnings History.

When will Aetna make its next earnings announcement?

Aetna is scheduled to release their next quarterly earnings announcement on Monday, July, 31st 2017. View Earnings Estimates for Aetna.

What guidance has Aetna issued on next quarter's earnings?

Aetna issued an update on its FY17 earnings guidance on Friday, May, 19th. The company provided EPS guidance of $8.80 to $9.00 for the period, compared to the Thomson Reuters consensus EPS estimate of $8.97.

Where is Aetna's stock going? Where will Aetna's stock price be in 2017?

20 brokerages have issued 12 month price objectives for Aetna's shares. Their forecasts range from $128.00 to $180.00. On average, they anticipate Aetna's share price to reach $151.50 in the next twelve months. View Analyst Ratings for Aetna.

What are analysts saying about Aetna stock?

Here are some recent quotes from research analysts about Aetna stock:

  • 1. Cantor Fitzgerald analysts commented, "There is life after Humana. CEO Mark Bertolini opened the meeting discussing life after Humana. With a continued focus to grow its government business, Mr. Bertolini indicated that Humana represented a means to an end." Instead, AET will now chose to build its government business organically. We believe the company will also pursue acquisitions to build out its capabilities in specific geographies. CFO Shawn Guertin identified Medicare as a great growth opportunity, but characterized Medicaid as a good opportunity. Growth in Medicaid slowed recently due to two contract losses and potential for structural changes to Medicaid exist." (5/12/2017)
  • 2. Royal Bank Of Canada analysts commented, "After the close on Monday, April 24, Humana pre-released 1Q17 EPS ahead of its investor meeting, which will be held on Tuesday, April 25. 1Q17 Adjusted EPS for the quarter was $2.75 vs. our estimate of $2.50 and FactSet consensus of $2.49." (4/24/2017)
  • 3. According to Zacks Investment Research, "Aetna expects long-term growth from its Government business. Cost-reduction initiatives are also likely to add to earnings. Growing ACO collaborations also pave the way for long term growth. A strong balance sheet is another positive. However, Aetna’s merger with Humana has been blocked by the U.S regulators. Aetna has also been incurring losses in its public exchange business and has been exiting exchanges to avoid losses from this business. Moreover, its membership growth remains under pressure. Increasing medical benefit ratios and cessation of share buyback are also likely to hurt margins. Year to date,  the stock of Aetna gained 3.8% lower than the gain of 4.4% logged by the Zacks categorized Medical Health Maintenance Organization industry. The company is set to release its first quarter earnings on May 2. The Zacks Consensus estimate is currently pegged at $2.34 for the first quarter reflecting 1.6% year over year growth." (4/5/2017)
  • 4. Oppenheimer Holdings, Inc. analysts commented, "Overall, we believe Humana is well positioned for growth, given the political support in Washington, ample strategic capital to deploy and the potential for upside to its current earnings base."Ultimately, this will also remain a desirable asset that could be acquired by another insurer." (3/31/2017)
  • 5. Jefferies Group LLC analysts commented, "AET's 4Q EPS was strong (beat by 13%), while initial 2017 guidance was below consensus on both the top and bottom line. As always, favorable prior period development (PPD) is excluded from the outlook and could generate upside. Looking to 2018, earnings growth should accelerate from buyback tailwinds and exiting HIX. We bump up our EPS projections for capital deployment, but remain Hold as the stock seems fairly valued." (2/1/2017)

Who are some of Aetna's key competitors?

Who are Aetna's key executives?

Aetna's management team includes the folowing people:

  • Mark T. Bertolini, Chairman of the Board, Chief Executive Officer
  • Karen S. Lynch, President
  • Shawn M. Guertin, Chief Financial Officer, Executive Vice President, Chief Enterprise Risk Officer
  • Thomas J. Sabatino Jr., Executive Vice President, General Counsel
  • Gary W. Loveman Ph.D., Executive Vice President - Consumer and Health Services
  • Margaret M. McCarthy, Executive Vice President - Operations and Technology
  • Harold L. Paz M.D., Executive Vice President, Chief Medical Officer
  • Francis S. Soistman Jr., Executive Vice President - Government Services
  • Edward J. Ludwig, Lead Independent Director
  • Fernando G. Aguirre, Independent Director

Who owns Aetna stock?

Aetna's stock is owned by a number of of retail and institutional investors. Top institutional investors include BlackRock Inc. (0.00%), Vanguard Group Inc. (0.00%), State Street Corp (6.53%), Wellington Management Group LLP (0.00%), FMR LLC (0.00%) and Alliancebernstein L.P. (0.00%). Company insiders that own Aetna stock include Francis S Soistman Jr, Franklin Barbara Hackman, Gary W Loveman, Jeffrey E Garten, Joseph M Zubretsky, Margaret M Mccarthy, Mark T Bertolini, Molly Joel Coye and Shawn M Guertin. View Institutional Ownership Trends for Aetna.

Who sold Aetna stock? Who is selling Aetna stock?

Aetna's stock was sold by a variety of institutional investors in the last quarter, including Clearbridge Investments LLC, Jana Partners LLC, OZ Management LP, Wellington Management Group LLP, OppenheimerFunds Inc., Schroder Investment Management Group, Jennison Associates LLC and Janus Capital Management LLC. Company insiders that have sold Aetna stock in the last year include Francis S Soistman Jr, Jeffrey E Garten, Margaret M Mccarthy, Mark T Bertolini and Shawn M Guertin. View Insider Buying and Selling for Aetna.

Who bought Aetna stock? Who is buying Aetna stock?

Aetna's stock was acquired by a variety of institutional investors in the last quarter, including BlackRock Inc., Vanguard Group Inc., AQR Capital Management LLC, UBS Asset Management Americas Inc., NN Investment Partners Holdings N.V., Victory Capital Management Inc., Prudential Financial Inc. and Seatown Holdings Pte. Ltd.. View Insider Buying and Selling for Aetna.

How do I buy Aetna stock?

Shares of Aetna can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Aetna's stock price today?

One share of Aetna stock can currently be purchased for approximately $151.19.

MarketBeat Community Rating for Aetna (NYSE AET)
Community Ranking:  3.1 out of 5 (  )
Outperform Votes:  586 (Vote Outperform)
Underperform Votes:  345 (Vote Underperform)
Total Votes:  931
MarketBeat's community ratings are surveys of what our community members think about Aetna and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Aetna (NYSE:AET) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 6 Hold Ratings, 13 Buy Ratings, 1 Strong Buy Rating
Consensus Rating:Buy (Score: 2.75)
Consensus Price Target: $151.50 (0.21% upside)

Analysts' Ratings History for Aetna (NYSE:AET)
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
6/28/2017Citigroup Inc.Initiated CoverageBuy -> Focus List$180.00LowView Rating Details
6/9/2017Royal Bank Of CanadaBoost Price TargetOutperform$147.00 -> $162.00LowView Rating Details
6/6/2017Morgan StanleyInitiated CoverageOverweight -> Overweight$162.00MediumView Rating Details
5/30/2017ArgusReiterated RatingBuy$145.00 -> $165.00LowView Rating Details
5/27/2017Cowen and CompanySet Price TargetBuy$145.00 -> $170.00N/AView Rating Details
5/17/2017Credit Suisse GroupReiterated RatingBuy$155.00LowView Rating Details
5/17/2017Bank of America CorporationReiterated RatingBuy$160.00 -> $168.00MediumView Rating Details
5/16/2017Stifel NicolausBoost Price TargetBuy -> Buy$150.00 -> $158.00LowView Rating Details
5/15/2017Barclays PLCReiterated RatingOverweight$162.00LowView Rating Details
5/12/2017Cantor FitzgeraldReiterated RatingBuy$150.00LowView Rating Details
5/11/2017Cleveland ResearchUpgradeNeutral -> BuyLowView Rating Details
5/3/2017Jefferies Group LLCReiterated RatingHold$133.00 -> $140.00LowView Rating Details
4/5/2017Deutsche Bank AGInitiated CoverageHold$135.00LowView Rating Details
4/3/2017CIBCReiterated RatingOutperformLowView Rating Details
3/31/2017Oppenheimer Holdings, Inc.Reiterated RatingOutperformLowView Rating Details
1/31/2017Sanford C. BernsteinDowngradeOutperform -> Market PerformN/AView Rating Details
1/24/2017Leerink SwannDowngradeOutperform -> Market Perform$135.00N/AView Rating Details
1/4/2017Piper Jaffray CompaniesInitiated CoverageNeutral$136.00N/AView Rating Details
9/22/2016Evercore ISIInitiated CoverageBuy$128.00N/AView Rating Details
8/17/2016FBR & CoReiterated RatingHoldN/AView Rating Details
7/21/2016Wolfe ResearchDowngradeOutperform -> Peer PerformN/AView Rating Details
6/2/2016Wells Fargo & CompanyReiterated RatingBuyN/AView Rating Details
5/16/2016Sterne Agee CRTReiterated RatingBuyN/AView Rating Details
2/3/2016BMO Capital MarketsBoost Price TargetOutperform$128.00 -> $129.00N/AView Rating Details
2/2/2016WedbushLower Price TargetNeutral$130.00 -> $120.00N/AView Rating Details
10/30/2015J P Morgan Chase & CoLower Price Target$144.00 -> $141.00N/AView Rating Details
8/4/2015Susquehanna Bancshares IncReiterated RatingBuy$135.00N/AView Rating Details
7/7/2015S&P Equity ResearchReiterated RatingStrong-Buy$150.00N/AView Rating Details
(Data available from 6/28/2015 forward)


Earnings History for Aetna (NYSE:AET)
Earnings by Quarter for Aetna (NYSE:AET)
Earnings History by Quarter for Aetna (NYSE AET)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/2/2017Q1 2017$2.36$2.71$15.39 billion$15.17 billionViewListenView Earnings Details
1/31/2017Q416$1.44$1.63$15.84 billion$15.73 billionViewListenView Earnings Details
10/27/2016Q316$2.02$2.07$15.71 billion$15.78 billionViewListenView Earnings Details
8/2/2016Q216$2.12$2.21$15.69 billion$15.95 billionViewListenView Earnings Details
4/28/2016Q116$2.23$2.30$15.46 billion$15.69 billionViewListenView Earnings Details
2/1/2016Q415$1.21$1.37$14.93 billion$15.09 billionViewListenView Earnings Details
10/29/2015Q315$1.77$1.90$15.22 billion$15.00 billionViewListenView Earnings Details
8/4/2015Q215$1.82$2.05$15.43 billion$15.13 billionViewListenView Earnings Details
4/28/2015Q115$1.96$2.39$15.48 billion$15.09 billionViewListenView Earnings Details
2/3/2015Q414$1.22$1.22$14.59 million$14.77 millionViewListenView Earnings Details
10/28/2014Q214$1.58$1.79$14.63 billion$14.70 billionViewListenView Earnings Details
7/29/2014Q114$1.61$1.69$13.98 billion$14.50 billionViewListenView Earnings Details
4/24/2014Q413$1.56$1.98$13.69 billion$13.97 billionViewListenView Earnings Details
2/6/2014Q313$1.36$1.34$13.14 billion$13.13 billionViewListenView Earnings Details
10/29/2013Q213$1.53$1.53$12.89 billion$12.99 billionViewListenView Earnings Details
7/30/2013Q2 2013$1.39$1.52$12.02 billion$11.56 billionViewListenView Earnings Details
4/30/2013Q1 2013$1.38$1.50$9.65 billion$9.51 billionViewListenView Earnings Details
1/31/2013Q4 2012$0.96$0.94$8.97 billion$8.96 billionViewListenView Earnings Details
10/25/2012Q312$1.34$1.55$8.96 billion$8.90 billionViewN/AView Earnings Details
7/31/2012$1.25$1.31ViewN/AView Earnings Details
4/26/2012$1.39$1.34ViewN/AView Earnings Details
2/1/2012$0.96$0.97ViewN/AView Earnings Details
10/27/2011$1.14$1.40ViewN/AView Earnings Details
7/27/2011$1.07$1.35ViewN/AView Earnings Details
4/28/2011$0.97$1.43ViewN/AView Earnings Details
2/4/2011$0.62$0.63ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Aetna (NYSE:AET)
2017 EPS Consensus Estimate: $8.65
2018 EPS Consensus Estimate: $9.77
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20174$2.29$2.40$2.33
Q2 20174$2.30$2.38$2.35
Q3 20174$2.23$2.42$2.29
Q4 20174$1.63$1.74$1.68
Q1 20181$2.70$2.70$2.70
Q2 20181$2.64$2.64$2.64
Q3 20181$2.55$2.55$2.55
Q4 20181$1.88$1.88$1.88
(Data provided by Zacks Investment Research)


Current Dividend Information for Aetna (NYSE:AET)
Next Dividend:7/28/2017
Annual Dividend:$2.00
Dividend Yield:1.32%
Dividend Growth:7.70% (3 Year Average)
Payout Ratio:62.31% (Trailing 12 Months of Earnings)
22.25% (Based on This Year's Estimates)
20.12% (Based on Next Year's Estimates)
Dividend Payments by Quarter for Aetna (NYSE:AET)

Dividend History by Quarter for Aetna (NYSE AET)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading and Institutional Ownership History for Aetna (NYSE:AET)
Insider Ownership Percentage: 1.14%
Institutional Ownership Percentage: 91.88%
Insider Trades by Quarter for Aetna (NYSE:AET)
Institutional Ownership by Quarter for Aetna (NYSE:AET)
Insider Trades by Quarter for Aetna (NYSE:AET)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
6/7/2017Margaret M MccarthyEVPSell27,028$149.23$4,033,388.44View SEC Filing  
5/17/2017Mark T BertoliniChairmanSell103,547$140.79$14,578,382.13View SEC Filing  
3/23/2017Shawn M GuertinInsiderSell29,602$129.35$3,829,018.70View SEC Filing  
3/8/2017Francis S Soistman JrVPSell6,607$131.98$871,991.86View SEC Filing  
9/7/2016Jeffrey E. GartenDirectorSell7,100$116.51$827,221.00View SEC Filing  
8/23/2016Shawn M GuertinInsiderSell45,328$120.21$5,448,878.88View SEC Filing  
5/10/2016Margaret M MccarthyEVPSell39,169$114.45$4,482,892.05View SEC Filing  
5/3/2016Mark T BertoliniCEOSell33,510$114.00$3,820,140.00View SEC Filing  
3/15/2016Gary W LovemanEVPBuy8,970$111.45$999,706.50View SEC Filing  
2/22/2016Molly Joel CoyeDirectorSell1,175$106.28$124,879.00View SEC Filing  
12/23/2015Margaret M MccarthyEVPSell18,373$109.97$2,020,478.81View SEC Filing  
12/22/2015Mark T. BertoliniCEOSell26,996$110.00$2,969,560.00View SEC Filing  
8/14/2015Joseph M ZubretskyEVPSell179,087$118.66$21,250,463.42View SEC Filing  
8/13/2015Franklin Barbara HackmanDirectorSell2,064$118.47$244,522.08View SEC Filing  
3/31/2015Joseph M ZubretskyEVPSell200,000$107.96$21,592,000.00View SEC Filing  
3/27/2015Joseph M ZubretskyEVPSell86,958$107.24$9,325,375.92View SEC Filing  
3/26/2015Joseph M ZubretskyInsiderSell162,066$106.98$17,337,820.68View SEC Filing  
3/26/2015Margaret M MccarthyEVPSell27,670$106.04$2,934,126.80View SEC Filing  
3/25/2015Franklin Barbara HackmanDirectorSell3,000$108.75$326,250.00View SEC Filing  
3/17/2015William James CasazzaVPSell14,000$105.07$1,470,980.00View SEC Filing  
3/2/2015Molly Joel CoyeDirectorSell2,500$100.27$250,675.00View SEC Filing  
2/10/2015Rajan ParmeswarVPSell5,300$95.60$506,680.00View SEC Filing  
6/16/2014Molly Joel CoyeDirectorSell1,650$80.60$132,990.00View SEC Filing  
6/12/2014William James CasazzaVPSell15,906$80.58$1,281,705.48View SEC Filing  
5/27/2014Franklin Barbara HackmanDirectorSell2,665$77.26$205,897.90View SEC Filing  
2/19/2014Rajan ParmeswarVPSell3,600$69.46$250,056.00View SEC Filing  
12/30/2013Mark BertoliniCEOSell130,272$68.08$8,868,917.76View SEC Filing  
12/27/2013William James CasazzaVPSell10,299$68.25$702,906.75View SEC Filing  
8/26/2013William James CasazzaVPSell15,745$64.66$1,018,071.70View SEC Filing  
6/18/2013William James CasazzaVPSell40,598$62.00$2,517,076.00View SEC Filing  
5/21/2013Molly Joel CoyeDirectorSell2,000$60.38$120,760.00View SEC Filing  
5/20/2013Joseph P NewhouseDirectorSell14,000$59.15$828,100.00View SEC Filing  
5/15/2013Rajan ParmeswarVPSell1,435$60.13$86,286.55View SEC Filing  
2/6/2013Karen RohanVPBuy4,035$49.53$199,853.55View SEC Filing  
(Data available from 1/1/2013 forward)


Headline Trends for Aetna (NYSE:AET)
Latest Headlines for Aetna (NYSE:AET)
DateHeadline logoInterpace inks national contract with Aetna for thyroid tests; shares ahead 15% premarket - June 28 at 8:43 AM logoAetna Inc. (AET) Research Coverage Started at Citigroup Inc. - June 28 at 8:19 AM logoAetna Inc. (AET) Receives Consensus Rating of "Buy" from Brokerages - June 28 at 12:06 AM logoMedtronic (MDT) Partners with Aetna for Type 1 & 2 Diabetes - Nasdaq - June 27 at 3:27 PM
News IconMedtronic deal with Aetna ties insulin pump payment to patient results - Business Insider - June 27 at 4:34 AM logoCBO evaluates Senate health bill - Seeking Alpha - June 27 at 4:34 AM logoMedtronic deal with Aetna ties insulin pump payment to patient results - Reuters - June 26 at 11:31 PM logoAetna Inks New Deal to Improve Healthcare in North Carolina - June 26 at 3:48 PM logo3 Best Healthcare Dividend Stocks of the 21st Century (So Far) - June 24 at 3:23 PM logoWhite House Confident Healthcare Bill Passes Before August Recess - June 23 at 3:53 PM logoHealth care on pace from best week of the year - June 23 at 3:53 PM logoGOP to release healthcare bill - Seeking Alpha - June 22 at 8:18 PM logoGOP healthcare plan long on repeals - Seeking Alpha - June 22 at 8:18 PM logoRowdMap, Inc. Joins Aetna, Humana, United Healthcare, and Memorial Health ... - June 22 at 3:17 PM logoRowdMap, Inc. Joins Aetna, Humana, United Healthcare, and Memorial Health System at the Georgia Society for Managed Care Summer Conference - June 22 at 12:36 PM logoMark Bertolini: We’re Moving Aetna, but not telling anybo... - June 22 at 12:36 PM logoMark Bertolini: We’re moving Aetna, but not telling anybody where yet - June 22 at 12:36 PM logoSenate Republicans unveil Obamacare replacement bill with tough debate expected - June 22 at 12:36 PM logoBRIEF-AETNA AND COMMUNITY CARE PHYSICIAN NETWORK SIGN COLLABORATIVE AGREEMENT - June 21 at 4:02 PM logoAetna and Community Care Physician Network Sign Collaborative Agreement - June 21 at 4:02 PM logoGovernment health insurance markets holding up--barely - June 21 at 4:02 PM logoAetna Inc. (AET) Expected to Post Quarterly Sales of $15.30 Billion - June 21 at 9:37 AM logoU.S. banks, corporations establish principles for cyber risk ratings firms - June 20 at 3:54 PM logoFlorida governor tries again to lure Connecticut firms - June 19 at 5:47 PM logoAetna Inc. (AET) Expected to Post Earnings of $2.33 Per Share - June 19 at 4:12 PM logoIs Aetna (AET) a Great Stock for Value Investors? - June 19 at 3:26 PM logo​Sutter Health, Aetna announce new Northern California health ... - Sacramento Business Journal - June 15 at 3:58 PM logo​Sutter Health, Aetna announce new Northern California health plan - June 13 at 9:59 PM logoAetna Target of Unusually High Options Trading (AET) - June 13 at 5:18 PM logoKey insurer Centene plans to expand health exchange presence - June 13 at 3:20 PM logoSutter Health and Aetna to Establish New Health Plan in Northern California - June 13 at 3:20 PM logoIowa may be first state with no health insurers on exchange - June 12 at 4:50 PM logoDoctors Fight GOP Senate's Medicaid Clawback - June 11 at 3:23 PM logoAetna Inc (AET) EVP Sells $4,033,388.44 in Stock - June 9 at 4:14 PM logoMajor Obamacare hikes in NY? - Seeking Alpha - June 9 at 3:27 PM logoPutting Failed Aetna Deal Behind It, Humana Is Refocused On Growth; Analyst Upgrades The Stock - Benzinga - June 9 at 3:27 PM logoPutting Failed Aetna Deal Behind It, Humana Is Refocused On Growth; Analyst Upgrades The Stock - June 9 at 3:27 PM logoRoyal Bank of Canada Raises Aetna Inc (AET) Price Target to $162.00 - June 9 at 7:56 AM logoATALIAN Global Services, Inc. Expands US Footprint through the Acquisition of Aetna Integrated Services, Inc. - June 7 at 8:28 PM logo[$$] Hartford’s Finances Spotlight Property-Tax Quandary - June 6 at 8:36 PM logoAetna Inc (AET) Coverage Initiated by Analysts at Morgan Stanley - June 6 at 5:32 PM logoAnthem to leave Ohio's Obamacare insurance market in 2018 - June 6 at 3:35 PM logoThese Health Insurance Stocks Just Hit All-Time Highs: Buy, Sell, or Hold? - June 6 at 3:35 PM logo[$$] Gov. Cuomo Adds Emergency Regulations to Maintain Obamacare - June 5 at 11:37 PM logoJust what does Aetna want? - Boston Business Journal - June 3 at 3:23 PM logoAetna (AET) Up 4.3% Since Earnings Report: Can It Continue? - June 2 at 4:22 PM logoJust what does Aetna want? - June 2 at 4:22 PM logoAetna Inc (AET) Given Average Recommendation of "Buy" by Brokerages - June 2 at 2:08 PM logoHealth insurer Aetna looking to move headquarters out of Connecticut - Reuters - June 1 at 8:31 PM logoAetna to Move Headquarters Out of Connecticut - May 31 at 8:23 PM



Aetna (AET) Chart for Wednesday, June, 28, 2017

This page was last updated on 6/28/2017 by Staff